Literature DB >> 22178140

mTOR activates hypoxia-inducible factor-1α and inhibits neuronal apoptosis in the developing rat brain during the early phase after hypoxia-ischemia.

Hongju Chen1, Tao Xiong, Yi Qu, Fengyan Zhao, Donna Ferriero, Dezhi Mu.   

Abstract

The mammalian target of rapamycin (mTOR) exerts neuroprotective effects under hypoxic or ischemic conditions. To explore whether mTOR participates in neuroprotective signaling through regulation of hypoxia-inducible factor-1α (HIF-1α), vascular endothelial growth factor (VEGF) and neuronal apoptosis in developing rat brain with hypoxia-ischemia (HI), we operated on postnatal day 10 rats by ligating the common carotid artery followed by exposure to systemic hypoxia. Brains were collected at various intervals to detect the expression of mTOR, phosphorylated mTOR (p-mTOR), HIF-1α, VEGF and cleaved caspase 3 (CC3), using immunohistochemistry and Western blot analysis. We also used terminal deoxynucleotidyl transferase-mediated dUTP-nick end labeling (TUNEL) to detect neuronal apoptosis. The p-mTOR protein expression increased at 2h after HI, peaked at 8h, lasted 24h, and then dropped to the basal level. Also, the expression of HIF-1α and VEGF was significantly enhanced and peaked at 8h after HI. Up-regulated expression of CC3 was observed at 2h, peaked at 24h, and lasted 72h after HI. Increased neuronal apoptosis is associated with reduced HIF-1α and VEGF expression. Furthermore, pretreatment with rapamycin, a mTOR specific inhibitor, significantly inhibited HIF-1α and VEGF protein after HI. The expression of CC3 and the number of TUNEL-positive cells were up-regulated at 8h and down-regulated at 24h after HI in the rapamycin-treated group. Our findings suggest that mTOR may participate in the regulation of HIF-1α, VEGF and neuronal apoptosis, serving neuroprotective functions after HI in developing rat brain.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22178140      PMCID: PMC3525671          DOI: 10.1016/j.neulet.2011.11.058

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  24 in total

Review 1.  Pathological apoptosis in the developing brain.

Authors:  Klas Blomgren; Marcel Leist; Laurent Groc
Journal:  Apoptosis       Date:  2007-05       Impact factor: 4.677

2.  Antiangiogenic potential of the Mammalian target of rapamycin inhibitor temsirolimus.

Authors:  Donatella Del Bufalo; Ludovica Ciuffreda; Daniela Trisciuoglio; Marianna Desideri; Francesco Cognetti; Gabriella Zupi; Michele Milella
Journal:  Cancer Res       Date:  2006-06-01       Impact factor: 12.701

3.  Neuronal cell death in neonatal hypoxia-ischemia.

Authors:  Frances J Northington; Raul Chavez-Valdez; Lee J Martin
Journal:  Ann Neurol       Date:  2011-05       Impact factor: 10.422

Review 4.  Cellular oxygen sensing, signalling and how to survive translational arrest in hypoxia.

Authors:  M Fähling
Journal:  Acta Physiol (Oxf)       Date:  2008-09-01       Impact factor: 6.311

5.  N-myc is a novel regulator of PI3K-mediated VEGF expression in neuroblastoma.

Authors:  J Kang; P G Rychahou; T A Ishola; J M Mourot; B M Evers; D H Chung
Journal:  Oncogene       Date:  2008-02-18       Impact factor: 9.867

6.  Relationship between HIF-1alpha expression and neuronal apoptosis in neonatal rats with hypoxia-ischemia brain injury.

Authors:  Lihua Li; Yi Qu; Jinhui Li; Ying Xiong; Meng Mao; Dezhi Mu
Journal:  Brain Res       Date:  2007-09-05       Impact factor: 3.252

7.  Rapamycin reverses NPM-ALK-induced glucocorticoid resistance in lymphoid tumor cells by inhibiting mTOR signaling pathway, enhancing G1 cell cycle arrest and apoptosis.

Authors:  L Gu; J Gao; Q Li; Y P Zhu; C S Jia; R Y Fu; Y Chen; Q K Liao; Z Ma
Journal:  Leukemia       Date:  2008-08-07       Impact factor: 11.528

8.  Enhancement of autophagic flux after neonatal cerebral hypoxia-ischemia and its region-specific relationship to apoptotic mechanisms.

Authors:  Vanessa Ginet; Julien Puyal; Peter G H Clarke; Anita C Truttmann
Journal:  Am J Pathol       Date:  2009-10-08       Impact factor: 4.307

9.  Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy.

Authors:  P García-Maceira; J Mateo
Journal:  Oncogene       Date:  2008-11-03       Impact factor: 9.867

10.  Autophagy in hypoxia-ischemia induced brain injury: evidence and speculations.

Authors:  Walter Balduini; Silvia Carloni; Giuseppe Buonocore
Journal:  Autophagy       Date:  2009-02-07       Impact factor: 16.016

View more
  25 in total

1.  [Expression rhythm of autophagic gene in neurons of neonatal rats with hypoxia/ischemia and its regulatory mechanism].

Authors:  Shi-Ping Li; Jiang-Hu Zhu; Feng-Yan Zhao; Zhen Zheng; De-Zhi Mu; Yi Qu
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2017-08

2.  The underlying mechanisms involved in the protective effects of ischemic postconditioning.

Authors:  Rong Xie; Jinquan Li; Heng Zhao
Journal:  Cond Med       Date:  2018

3.  Alteration in Downstream Hypoxia Gene Signaling in Neonatal Glutathione Peroxidase Overexpressing Mouse Brain after Hypoxia-Ischemia.

Authors:  R Ann Sheldon; Raha Sadjadi; Matthew Lam; Russell Fitzgerald; Donna M Ferriero
Journal:  Dev Neurosci       Date:  2015-03-17       Impact factor: 2.984

4.  Hypoxia inducible factor 1α promotes survival of mesenchymal stem cells under hypoxia.

Authors:  Bingke Lv; Feng Li; Jie Fang; Limin Xu; Chengmei Sun; Jianbang Han; Tian Hua; Zhongfei Zhang; Zhiming Feng; Xiaodan Jiang
Journal:  Am J Transl Res       Date:  2017-03-15       Impact factor: 4.060

5.  Hypoxia induces a phase transition within a kinase signaling network in cancer cells.

Authors:  Wei Wei; Qihui Shi; Francoise Remacle; Lidong Qin; David B Shackelford; Young Shik Shin; Paul S Mischel; R D Levine; James R Heath
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-25       Impact factor: 11.205

Review 6.  The mTOR signalling cascade: paving new roads to cure neurological disease.

Authors:  Peter B Crino
Journal:  Nat Rev Neurol       Date:  2016-06-24       Impact factor: 42.937

7.  Effects of rapamycin on cerebral oxygen supply and consumption during reperfusion after cerebral ischemia.

Authors:  O Z Chi; S Barsoum; N M Vega-Cotto; E Jacinto; X Liu; S J Mellender; H R Weiss
Journal:  Neuroscience       Date:  2015-12-29       Impact factor: 3.590

8.  Topical rapamycin suppresses the angiogenesis pathways induced by pulsed dye laser: molecular mechanisms of inhibition of regeneration and revascularization of photocoagulated cutaneous blood vessels.

Authors:  Wenbin Tan; Wangcun Jia; Victor Sun; Martin C Mihm; J Stuart Nelson
Journal:  Lasers Surg Med       Date:  2012-12-04       Impact factor: 4.025

9.  Mammalian target of rapamycin cell signaling pathway contributes to the protective effects of ischemic postconditioning against stroke.

Authors:  Rong Xie; Peng Wang; Michelle Cheng; Robert Sapolsky; Xunming Ji; Heng Zhao
Journal:  Stroke       Date:  2014-07-10       Impact factor: 7.914

10.  Canagliflozin attenuates lipotoxicity in cardiomyocytes and protects diabetic mouse hearts by inhibiting the mTOR/HIF-1α pathway.

Authors:  Pengbo Sun; Yangyang Wang; Yipei Ding; Jingyi Luo; Jin Zhong; Naihan Xu; Yaou Zhang; Weidong Xie
Journal:  iScience       Date:  2021-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.